Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

- Read more about Gene that triggers sepsis identified
Opening the door for the development of new treatment of the lethal disease sepsis, scientists have identified a gene that triggers the inflammatory condition.
- Read more about PM highlights need for organ donations
Prime Minister Narendra Modi on Sunday highlighted the need for organ donation in the country and encouraged people for it.
- Read more about Pain threshold rises with altered brain chemistry
The number of opiate receptors in the brain, critical in the modulation of pain behaviour, increase to combat severe pain in arthritis sufferers, according to a study.

[adsense:336x280:8701650588]
- Read more about Young Alzheimer's risk carriers show altered brain function
Young adults with genetically-increased Alzheimer's risk have altered activation patterns in a brain region that is crucial for spatial navigation, a study has found.
- Read more about Research reveals how cells repair DNA damage
Danish researchers have discovered a previously unknown function in histones -- responsible for packaging the DNA into structural units -- that will help improve understanding of how cells protect and repair DNA damage.
- Read more about One stop diagnostics system showcased at IPE 2015
One stop diagnostics and patient management system "Healthcube Pro" capable of executing 32 tests at the same time was the showstopper at the fourth edition of Indian Pharma Expo 2015 which opened on Saturday.
- Read more about Novartis' Cosentyx receive CHMP recommendation for approval to treat ankylosing spondylitis & psoriatic arthritis
The Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Novartis' Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients. Cosentyx is the first of a new class of medicines called interleukin-17A (IL-17A) inhibitors to be recommended for AS and PsA - conditions that affect around five million people in Europe.
- Read more about FDA approves new therapy for certain types of advanced soft tissue sarcoma
U.S. Food and Drug Administration approved Yondelis (trabectedin), a chemotherapy, for the treatment of specific soft tissue sarcomas (STS) – liposarcoma and leiomyosarcoma – that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who previously received chemotherapy that contained anthracycline.
- Read more about Ambry Genetics launch new epilepsy genetic testing panels
Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, announced that it is launching a new suite of seven genetic testing panels for epilepsy.
Tests can be ordered from November 6 with the first samples expected to be tested on November 9.
- Read more about AbbVie Upgrade U.S. Labels for VIEKIRA PAK® and TECHNIVIE™
In consultation with the U.S. Food and Drug Administration (FDA), the U.S. Product Inserts (USPI) for VIEKIRA PAK® (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) and TECHNIVIE™ (ombitasvir, paritaprevir, and ritonavir tablets) have been updated from 'not recommended in Child Pugh B patients' to a contraindication in patients with Child-Pugh B cirrhosis. The updated USPI for VIEKIRA PAK also includes a recommendation for physicians to assess evidence of hepatic decompensation prior to treatment and during treatment in cirrhotic patients.